CLINICAL STEM CELLS PL

Sydney, Australia

About us
We are a research and development biotech company engaged in the clinical translation of stem cell therapy. 
Our research is published in international peer reviewed medical and science journals (see Publications page). The research has a focus on integrating advanced stem cell techniques with established current medical treatments, and natural compounds such as the polyphenols found in plants and herbs. The laboratory is well equipped with state of the art biotechnology equipment including mass spectrometry, high performance liquid chromatography, separation chromatography, photodiode array and fluorescence spectroscopy, thermography, flow cytometry, multiplex assay, high resolution optical microscopy, dark field and time lapse microscopy. Stem cell research examines clinical outcomes from injected autologous stem cell procedures. In addition, we research peptides and biomolecules involved in stem cell recruitment, expansion and differentiation. 

Dr E. Russell Vickers BDS, MArt, MDSc, MScMed, PhD, FFPMANZCA, DipHerbalMed. 
Dr Vickers is the Director and an Oral & Maxillofacial Surgeon. In addition, he is qualified in herbal medicine and is an analytical and peptide chemist. Dr Vickers holds an appointment as Clinical Senior Lecturer at Sydney Medical School, University of Sydney, Adjunct Associate Professor at University of Queensland Dental School. He was appointed as the Balthasar Research Scholar at the University of Sydney.  Dr Vickers completed his training in stem cells in 2010 at the Australian Government Stemcore Facility, University of Queensland.

Patient enquiries
A/Professor Vickers consults patients at the Rosebery Medical Centre, 530 Botany Road, Rosbery, Sydney, Australia.
It is situated close to Sydney International Airport and has bus, rail and road links.
The Rosbery Medical Centre is part of the Olympus Health Group. Please go to contact us page for further information
email: rosebery@olympushealthgroup.com.au
phone: +612 9318 7380, 1300 6725 629
website www.olympushealthgroup.com.au

Recent developments
Hair follicle stem cell activation using a zinc-peptide for the treatment of hair loss (androgenetic alopecia). 

RECENT PUBLICATIONS
  1. Vickers ER (2017) An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia. Hair Ther Transplant 7:147. doi:10.4172/2167-0951.1000147
  2. Vickers ER, Karsten E, et al. (2014). A preliminary report on stem cell therapy for neuropathic pain in humans. J Pain Res. 2014 May 8;7:255-63. doi: 10.2147/JPR.S63361. eCollection 2014. PMID: 24855388
  3. Vickers ER. Neuropathic orofacial pain: Diagnosis and multimodal management. MedicineToday 2015, 16(9), 16-24.
  4. Vickers ER, Woodcock KL. Raspberry leaf herbal extract significantly reduces pain and inflammation in oral lichen planus patients – a case series analysis. Open Journal of Dentistry and Oral Medicine 2015, 3(3), 73 – 81. DOI: 10.13189/ojdom.2015.030303
  5. Eynab Alshelh, Flavia Di Pietro, Andrew Youssef, Jenna Reeves, Paul Macey, E.Russell Vickers, Chris Peck, Greg Murray, and Luke Henderson. Chronic neuropathic pain: it's about the rhythm. The Journal of Neuroscience, 20 January 2016, 36(3):1008-1018; doi:10.1523/JNEUROSCI.2768-15.2016
  6. Vickers ER Manual of Orofacial Pain (2 book chapters) (John Wiley Pub. Oxford. 2016)

image-57731-ERV small.jpg
Dr Russell Vickers
Director, Clinical Stem Cells.